Modular Medical, Inc. (MODD) financial statements (2020 and earlier)

Company profile

Business Address 800 WEST VALLEY PARKWAY
ESCONDIDO, CA 92025
State of Incorp. NV
Fiscal Year End March 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
Q3
9/30/2019
Q2
6/30/2019
Q1
3/31/2019
Q4
12/31/2018
Q3
9/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,7184,7765,7076,5547,1383,688
Cash and cash equivalents3,7184,7765,7076,5547,1383,688
Other current assets50101016220
Other undisclosed current assets48    
Total current assets:3,7734,7935,7166,5697,1603,688
Noncurrent Assets
Property, plant and equipment1109276766043
Intangible assets, net (including goodwill)  0000
Intangible assets, net (excluding goodwill)  0000
Other undisclosed noncurrent assets  8888
Total noncurrent assets:1109284846751
TOTAL ASSETS:3,8834,8865,8006,6537,2273,739
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2542452531796347
Accounts payable254245    
Other undisclosed accounts payable and accrued liabilities  2531796347
Total current liabilities:2542452531796347
Noncurrent Liabilities
Other undisclosed liabilities2086    
Total liabilities:2753312531796347
Stockholders' equity
Stockholders' equity attributable to parent3,6084,5555,5466,4747,1643,692
Common stock181818181816
Common stock, share subscribed but unissued, subscriptions receivable   20  
Additional paid in capital10,24210,0559,8999,6859,3885,178
Accumulated deficit(6,651)(5,518)(4,370)(3,248)(2,241)(1,502)
Total stockholders' equity:3,6084,5555,5466,4747,1643,692
TOTAL LIABILITIES AND EQUITY:3,8834,8865,8006,6537,2273,739

Income statement (P&L) ($ in thousands)

12/31/2019
Q3
9/30/2019
Q2
6/30/2019
Q1
3/31/2019
Q4
12/31/2018
Q3
9/30/2018
Q2
Operating expenses(1,136)(1,157)(1,138)(1,023)(751)(549)
Operating loss:(1,136)(1,157)(1,138)(1,023)(751)(549)
Nonoperating income21016 11 
Investment income, nonoperating21016   
Other nonoperating income    11 
Other undisclosed loss from continuing operations before equity method investments, income taxes   (22)  
Loss from continuing operations before equity method investments, income taxes:(1,134)(1,148)(1,122)(1,045)(739)(549)
Other undisclosed income from continuing operations before income taxes   39 5
Loss from continuing operations before income taxes:(1,134)(1,148)(1,122)(1,005)(739)(544)
Other undisclosed loss from continuing operations   (2)  
Net loss available to common stockholders, diluted:(1,134)(1,148)(1,122)(1,007)(739)(544)

Comprehensive Income ($ in thousands)

12/31/2019
Q3
9/30/2019
Q2
6/30/2019
Q1
3/31/2019
Q4
12/31/2018
Q3
9/30/2018
Q2
Net loss:(1,134)(1,148)(1,122)(1,007)(739)(544)
Comprehensive loss, net of tax, attributable to parent:(1,134)(1,148)(1,122)(1,007)(739)(544)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: